T cell toxicity induced by tigecycline binding to the mitochondrial ribosome
Open Access
- 1 May 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Abstract
Tetracyclines are essential bacterial protein synthesis inhibitors under continual development to combat antibiotic resistance yet suffer from unwanted side effects. Mitoribosomes - responsible for generating oxidative phosphorylation (OXPHOS) subunits - share structural similarities with bacterial machinery and may suffer from cross-reactivity. Since lymphocytes rely upon OXPHOS upregulation to establish immunity, we set out to assess the impact of ribosome-targeting antibiotics on human T cells. We find tigecycline, a third-generation tetracycline, to be the most cytotoxic compound tested. In vitro, 5–10 μM tigecycline inhibits mitochondrial but not cytosolic translation, mitochondrial complex I, III and IV expression, and curtails the activation and expansion of unique T cell subsets. By cryo-EM, we find tigecycline to occupy three sites on T cell mitoribosomes. In addition to the conserved A-site found in bacteria, tigecycline also attaches to the peptidyl transferase center of the large subunit. Furthermore, a third, distinct binding site on the large subunit, aligns with helices analogous to those in bacteria, albeit lacking methylation in humans. The data provide a mechanism to explain part of the anti-inflammatory effects of these drugs and inform antibiotic design.Keywords
All Related Versions
Funding Information
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Karolinska Institutet
This publication has 63 references indexed in Scilit:
- Inhibition of mitochondrial translation suppresses glioblastoma stem cell growthCell Reports, 2021
- Mitoribosome Profiling from Human Cell Culture: A High Resolution View of Mitochondrial Translation2020
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Inhibition of mitochondrial translation as a therapeutic strategy for human ovarian cancer to overcome chemoresistanceBiochemical and Biophysical Research Communications, 2019
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- Inhibition of mitochondrial translation effectively sensitizes renal cell carcinoma to chemotherapyBiochemical and Biophysical Research Communications, 2017
- Integrative Proteomics and Phosphoproteomics Profiling Reveals Dynamic Signaling Networks and Bioenergetics Pathways Underlying T Cell ActivationImmunity, 2017
- The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and DysfunctionImmunity, 2016
- Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical ResearchCell Reports, 2015
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid LeukemiaCancer Cell, 2011